Literature DB >> 18497461

Relation among left ventricular mass, insulin resistance, and hemodynamic parameters in type 2 diabetes.

Neiko Ozasa1, Yutaka Furukawa, Takeshi Morimoto, Eiji Tadamura, Toru Kita, Takeshi Kimura.   

Abstract

Increased left ventricular mass (LVM) is an independent cardiovascular risk marker, which often occurs independently of arterial blood pressure in type 2 diabetes. To investigate the factors related to the disproportionate increase in LVM in type 2 diabetes, we conducted a cross-sectional study. We studied 40 male type 2 diabetic patients aged 36 to 70 years with controlled blood pressure. Magnetic resonance imaging was used to measure LVM accurately. Radial arterial waveforms were recorded non-invasively by applanation tonometry to assess the hemodynamic status, radial augmentation index (AI) and time from forward peak to reflection peak (TPP). Glycemic control status and insulin resistance were evaluated by plasma HbA1c and homeostasis model assessment (HOMA) score, respectively. E/E', an echocardiographic parameter for left ventricular (LV) diastolic function, was also analyzed by echocardiography. Univariate analyses showed that HbA1c and TPP had trends toward a positive correlation with LVM indexed for body surface area (LVMI), whereas AI did not. When patients' age, heart rate, and systolic blood pressure were simultaneously included in the linear regression model, the TPP and HOMA score were independently related to LVMI (p<0.05 for each variable). Increased LVMI was accompanied with impaired LV diastolic function assessed by E/E'. In conclusion, the TPP and HOMA score were associated with a modest but clinically relevant increase in LVM in type 2 diabetes independently of arterial blood pressure. Pulse wave analysis may reveal hemodynamic alterations that affect LVM but that cannot be identified using a sphygmomanometer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18497461     DOI: 10.1291/hypres.31.425

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  6 in total

1.  Transplanted bone marrow mesenchymal stem cells protects myocardium by regulating 14-3-3 protein in a rat model of diabetic cardiomyopathy.

Authors:  Xiaoyan Dong; Fen Zhu; Qun Liu; Yuanheng Zhang; Jun Wu; Wen Jiang; Lei Zhang; Shuguang Dong
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

Review 2.  Diabetic cardiomyopathy, causes and effects.

Authors:  Sihem Boudina; Evan Dale Abel
Journal:  Rev Endocr Metab Disord       Date:  2010-03       Impact factor: 6.514

Review 3.  Is diabetic cardiomyopathy a specific entity?

Authors:  Mitja Letonja; Danijel Petrovič
Journal:  World J Cardiol       Date:  2014-01-26

4.  Impact of type 2 diabetes mellitus on left ventricular diastolic function in patients with essential hypertension: evaluation by volume-time curve of cardiac magnetic resonance.

Authors:  Wei-Feng Yan; Yue Gao; Yi Zhang; Ying-Kun Guo; Jin Wang; Li Jiang; Yuan Li; Zhi-Gang Yang
Journal:  Cardiovasc Diabetol       Date:  2021-03-25       Impact factor: 9.951

Review 5.  Diabetic cardiomyopathy.

Authors:  Omar Asghar; Ahmed Al-Sunni; Kaivan Khavandi; Ali Khavandi; Sarah Withers; Adam Greenstein; Anthony M Heagerty; Rayaz A Malik
Journal:  Clin Sci (Lond)       Date:  2009-05       Impact factor: 6.124

Review 6.  New Molecular Insights of Insulin in Diabetic Cardiomyopathy.

Authors:  Francisco Westermeier; Jaime A Riquelme; Mario Pavez; Valeria Garrido; Ariel Díaz; Hugo E Verdejo; Pablo F Castro; Lorena García; Sergio Lavandero
Journal:  Front Physiol       Date:  2016-04-12       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.